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Glomerular endothelial cell differentiation.
Background. Glomerular endothelial cells differ from most
other endothelial cells in that they are extraordinarily flattened
and highly fenestrated. In this differentiated form, they allow
formation of glomerular ultrafiltrate at a prodigious rate.
Methods. Molecular processes that dictate the development
and differentiation of glomerular endothelium are reviewed.
Results. During glomerular development, angioblasts already
present in the metanephric blastema well before any orga-
nized angiogenic sprouts invade the capillary cleft of develop-
ing nephrons at the comma and S-shape stages in response to
chemotactic and guiding cues from primitive podocytes. The
angioblasts then undergo homotypic aggregation into precapil-
lary cords as yet devoid of a lumen. Lumen development then
proceeds through the loss of superfluous endothelial cells by
apoptosis as well as flattening of the remaining viable endothe-
lial cells. The final step, fenestration, is critically dependent
on appropriate stimuli, most notably vascular endothelial
growth factor A (VEGF-A), from differentiated podocytes.
Current evidence suggests that the fenestrae of fully differen-
tiated glomerular endothelium can be lost within hours if the
VEGF-A stimulus is removed, and that the glomerular endothe-
liosis, loss of glomerular filtration rate (GFR) and proteinuria
observed in preeclampsia are due to the circulating inhibitor of
VEGF-A, soluble VEGF receptor 1 (VEGFR-1).
Conclusion. Differentiation of the glomerular endothelium
is highly dependent on podocyte-derived stimuli and their
loss leads to the derangements of glomerular function in
preeclampsia.
Like all other endothelial cells, glomerular endothe-
lial cells form the interface between blood and tissue
compartments, and function to regulate vasomotor tone,
hemostasis, and trafficking of leukocytes. But unlike
endothelium in most other capillary beds, the normal
glomerular endothelium is extraordinarily attenuated,
being only ∼ 50 to 150 nm high around the circumference
of the capillary loops [1]. Glomerular endothelium also is
densely perforated by transcellular fenestrae, which con-
stitute 30% to 50% of their surface area. The density and
size of glomerular endothelial cell fenestrae account, at
least in part, for the high permeability of the glomerular
capillary wall to water and small solutes [2], and loss of
fenestrae leads to a reduction in the glomerular filtration
rate (GFR) in disorders like preeclampsia.
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ORIGIN OF THE GLOMERULAR
ENDOTHELIUM
Vascularization of the developing kidney occurs largely
through in situ vasculogenesis. Individual angioblasts
bearing vascular endothelial growth factor receptor 2
(VEGFR-2) (Flk-1) are found in mouse metanephric
mesenchyme on embryonic day (E) 12, well before any
organized blood vessels are observed [3]. Unvascularized
metanephric blastema does not form glomerular capillar-
ies in vitro even under conditions that induce hypoxia-
inducible factor (HIF)-driven VEGF-A expression [4,
5]. However, when E12 metanephroi are implanted un-
der the renal capsule of mature kidneys, glomerular vas-
cularization occurs from cells intrinsic to the implanted
metanephric blastema, indicating that in situ vasculogen-
esis results in glomerular vascularization [3]. Neutralizing
antibodies to both, VEGF-A [6] and transforming growth
factor-b (TGF-b1) [7] markedly inhibit angioblast migra-
tion into the vascular cleft of nascent glomeruli of devel-
oping kidneys, suggesting that both mediators, interacting
with their respective receptors at the angioblast surface,
are critically important for this process. Invasion of the
vascular cleft by angioblasts furthermore may be guided
by neuropilin, the receptor for semaphorin III which also
binds the 165 kD isoform of VEGF-A [8]. A role for
podocyte ephrin-B2 in guiding angioblasts into the vascu-
lar clefts of developing nephrons has also been postulated
[9].
LUMEN FORMATION
Angioblasts invading the capillary cleft of develop-
ing nephrons at the comma- and S-shaped stages first
undergo homotypic aggregation into precapillary cords,
generally without a recognizable lumen [7, 10, 11].
Assembly of renal microvascular endothelial cells into
precapillary cords through homotypic interactions be-
tween cells appears to be regulated by Eph-like kinase
(ELK) receptors, as these are expressed by angioblasts
in the developing kidney and can induce aggregation
of cultured microvascular endothelial cells in response
the their ligand LERK-2 [12]. The process of endothe-
lial cell aggregation within the vascular cleft of develop-
ing glomeruli is reminiscent of the TGF-b1–dependent
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Fig. 1. Representation of development of fenestrae. (A) Angioblasts (endothelial cell precursors) invade the capillary cleft as precapillary cords,
devoid of capillary lumen. (B) A subset of undifferentiated endothelial cells begins the process of self-destruction (apoptosis). This process is
transforming growth factor-b1 (TGF-b1)-dependent. (C) Apoptotic endothelial cells collapse forming apoptotic bodies. Surviving endothelial cells
spread to cover the glomerular basement membrane. (D) Endothelial cells extend a thin layer of cytoplasm around the circumference of the
glomerular capillary wall. Transendothelial cell pores (fenestrae) develop in this flattened region. Fenestration is vascular endothelial growth factor
A (VEGF-A)-dependent.
migration and aggregation into precapillary cords of
glomerular endothelial cells in vitro [13]. Like glomerular
precapillary cords, such structures initially are solid cords
but develop a lumen after several days in culture. In vivo,
glomerular capillary lumen formation in developing rat
kidney involves removal of superfluous endothelial cells
from the precapillary cord by TGF-b1–induced apopto-
sis (Fig. 1) [11]. Hence, unlike the process of angiogenesis
in which a sprouting vessel containing a lumen invades
the tissue being vascularized, glomerular capillaries form
through homotypic endothelial cell interaction to form a
precapillary cord. The lumen is then shaped as a distinct
event requiring apoptosis of a subset of these endothelial
cells.
FORMATION OF FENESTRAE
The final steps in glomerular endothelial cell differenti-
ation involve flattening of the cells against the glomerular
basement membrane and formation of fenestrae. Fenes-
trae are plasma membrane-lined circular pores that per-
forate the flattened glomerular endothelium. Fenestrae
in nonglomerular endothelial cells are bridged by a very
thin, 5 to 6 nm diaphragm consisting of glycoproteins,
that is continuous with the outer leaflet of the plasma
membrane, and often contains a central knob [14]. It was
long held that glomerular fenestrae lack a diaphragm [15]
but recent work suggests that glomerular fenestrae, like
peritubular and other fenestrated endothelia, contain a
bridging diaphragm [16]. Actin microfilaments, which sur-
round fenestrae, have been postulated to regulate their
shape and diameter [17].
That VEGF regulates fenestrae formation was initially
suggested by Breier et al [18] who found that mature
fenestrated endothelium is typically located adjacent to
epithelial cells expressing VEGF at high levels, and that
the highest levels of VEGF mRNA are found in mature
glomerular podocytes. VEGF can rapidly induce fenes-
trae formation in capillaries of both skin and skeletal mus-
cle in vivo [19], and tumors secreting VEGF develop a
fenestrated neovasculature [20]. In the kidney, the ele-
gant work by Eremina et al [21] showed that podocyte
specific deletion of a single VEGF-A allele produces
glomeruli in which the glomerular capillary endothelium
fails to fully differentiate, in that it does not flatten or fen-
estrate. The glomerular lesion with this partial deletion of
podocyte VEGF-A resembles that found in preeclamp-
sia, as these mice were also noted to have significant
proteinuria. Podocyte-specific homozygous deletion of
VEGF-A produced a more severe lesion due to lack of en-
dothelial migration and differentiation. In patients with
preeclampsia, higher than normal concentrations of sol-
uble VEGFR-1 (sVEGFR-1) (sFlt-1), which inhibits the
interaction of VEGF-A with full-length transmembrane
VEGFR tyrosine kinases and their activation, are found
in plasma and correlate with the severity of the renal le-
sion [22]. Moreover, in mature mice given neutralizing
VEGF antibody or sVEGFR-1, rapid loss of endothelial
cell fenestrae, endothelial cell swelling, and proteinuria
were observed [23]. Finally, deletion of the podocyte-
specific transcription factor LMX1B in mice, which
results in the loss of many features of podocyte differenti-
ation, including a loss of VEGF-A expression, also results
in a glomerular endothelium that remains undifferenti-
ated in that it is thickened and fails to develop fenestrae
[24]. Taken together, these studies prove that the final dif-
ferentiation of glomerular endothelial cells is podocyte-
dependent, and that podocyte-derived VEGF-A is a
necessary mediator of glomerular endothelial cell differ-
entiation. Also of note, the rapid reversal of endothelial
cell fenestration that was observed when VEGF-A action
was inhibited in mice [23] suggests that the formation of
fenestrae is a very dynamic process.
VEGF-mediated induction of fenestrae in vitro re-
sults in fusion of intracellular vesicles [25], also known
as vesiculovacuolar organelles (VVO). VVOs contain
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caveolin-1 and are thought to represent precursors of
caveolae and fenestrae [26]. The protein PV-1, ini-
tially isolated from the apical plasma membrane of
pulmonary endothelium, is specifically associated with
the bridging diaphragms of endothelial fenestrae and
caveolae [27]. Induction of VVO fusion, furthermore, is
PV-1–dependent [28]. Because fenestral and caveolar di-
aphragms contain PV-1, and because fusion of PV-1 and
caveolin-1 containing VVOs is induced by VEGF and as-
sociated with the formation of transendothelial cell chan-
nels, it has been argued that endothelial cell fenestrae
represent fused caveolae, and that VEGF induces their
fusion. However, Esser et al [25] noted that caveolin-
1 is absent from fenestrae of cultured endothelial cells
and from fenestrae of choroid plexus endothelium in
vivo. It is also of note that PV-1 is uniquely absent
from glomerular endothelial cell fenestrae [26] despite
the fact that fenestral diaphragms are found in glomeru-
lar endothelial cell fenestrae [29]. To determine whether
glomerular endothelial cell fenestrae represent fused
caveoli, we examined human glomeruli by immunogold
electron microscopy, and found that the fenestrated re-
gion of glomerular endothelium is completely devoid
of caveolin-1. Furthermore, caveolin-1–deficient mice,
which do not form caveolae, nevertheless had a fully dif-
ferentiated glomerular endothelium with a fenestrae den-
sity similar to that of wild-type controls [30]. The lack of
PV-1 and caveolin-1 in glomerular fenestrae, and the find-
ing that caveolin-1–deficient mice make perfectly normal
glomerular fenestrae suggest strongly that fenestrae in
glomerular endothelial cells differ at the molecular level
from those in other vascular beds, and that they do not
represent fused caveolae.
CONCLUSION
The molecular mechanisms of glomerular endothelial
cell development and differentiation are increasingly well
understood. Steps in their development and differen-
tiation represent a unique set of interactions between
podocytes and the endothelial cells.
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